Alberta Investment Management Corporation »

Ani Pharmaceuticals shares owned by Alberta Investment Management Corporation

Quarter-by-quarter ownership of Ani Pharmaceuticals shares owned by Alberta Investment Management Corporation from 13F filings

Historical chart of Alberta Investment Management Corporation investment in Ani Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ani Pharmaceuticals held by Alberta Investment Management Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ani Pharmaceuticals by Alberta Investment Management Corporation

Quarter filed Position value Share count Share price at filing
2025-12-31 $38M 30M 1.26

More positions owned by Alberta Investment Management Corporation

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Western Digital Corp Note 3.000%11/1 (Principal)
Agnico (AEM)
Brookfield Corp Cl A Ltd Vt Sh (BN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Enbridge (ENB)
Bank Of Montreal Cadcom (BMO)
Interdigital Note 3.500% 6/0 (Principal)
Bk Nova Cad (BNS)
Seagate Hdd Cayman Note 3.500% 6/0 (Principal)

View all positions for Alberta Investment Management Corporation

Top funds holding Ani Pharmaceuticals

Camden Asset Management
Alberta Investment Management Corporation
Empyrean Capital Partners
Millennium Management
Citadel Advisors
Absolute Investment Advisers
BlackRock
Context Capital Management
Jpmorgan Chase & Co
Leucadia National Corporation
Point72 Asset Management
Polar Securities
Universal- Beteiligungs- und Servicegesellschaft mbH
Gabelli Funds
Susquehanna Advisors Group

View all funds holding Ani Pharmaceuticals